Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-009285
Filing Date
2024-03-27
Accepted
2024-03-27 21:07:37
Documents
1
Period of Report
2024-03-27

Document Format Files

Seq Description Document Type Size
1 form3-03282024_010328.html 3  
1 form3-03282024_010328.xml 3 4887
  Complete submission text file 0001415889-24-009285.txt   6626
Mailing Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121
Business Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Issuer) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210
Business Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210 (617) 951-5372
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (Reporting) CIK: 0001787092 (see all company filings)

State of Incorp.: E9
Type: 3 | Act: 34 | File No.: 001-41989 | Film No.: 24793118